Clinical Trial Detail

NCT ID NCT01807065
Title Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

prostate adenocarcinoma

Therapies

Sipuleucel-T

Age Groups: adult

No variant requirements are available.